Related Experiment Video

Updated: Feb 16, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.3K

Long-Term Prognosis after Myectomy in Hypertrophic Obstructive Cardiomyopathy with Severe Left Ventricular

Shuoyan An1, Chaomei Fan, Yinjian Yang

  • 1State Key Laboratory of Cardiovascular Disease, Heart Failure Center, Beijing, China.

Cardiology
|January 5, 2018
PubMed

Insights

Myectomy significantly reduces sudden cardiac death (SCD) risk in hypertrophic obstructive cardiomyopathy (HOCM) patients with severe left ventricular hypertrophy. Surgical intervention offers a lower incidence of cardiovascular mortality compared to medical management alone.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Medical Research

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) with severe left ventricular hypertrophy (≥30 mm) poses a high risk of sudden cardiac death (SCD).
  • Effective risk mitigation strategies for these high-risk patients are crucial.

Purpose of the Study:

  • To evaluate the incidence of SCD in HOCM patients with severe hypertrophy after undergoing myectomy.
  • To compare long-term outcomes, specifically cardiovascular mortality and SCD rates, between myectomy and medical management.

Main Methods:

  • Retrospective analysis of 244 HOCM patients with severe hypertrophy (2000-2013).
  • Comparison of outcomes between a myectomy group (118 patients) and a medical group (126 patients).
  • Long-term follow-up to assess annual cardiovascular mortality and SCD rates.

Main Results:

  • The myectomy group experienced a lower annual cardiovascular mortality rate (0.84%) versus the medical group (2.04%, p=0.041).
  • The annual SCD rate was significantly lower in the myectomy group (0.33%) compared to the medical group (1.40%, p=0.040).
  • Myectomy was independently associated with reduced rates of cardiovascular death and SCD via multivariate Cox regression analysis.

Conclusions:

  • Myectomy is associated with a reduced risk of cardiovascular death and SCD in HOCM patients with severe hypertrophy.
  • Surgical intervention (myectomy) demonstrates superior long-term outcomes compared to medical therapy alone for this high-risk patient cohort.
Abstract

Keywords:
Hypertrophic cardiomyopathyMyectomyVentricular arrhythmia

More Related Videos

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy08:34

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy

Published on: September 25, 2017

25.6K
A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure06:47

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure

Published on: November 29, 2018

10.1K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
534
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
591
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
606
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
483
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
629
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
372